SOX2-driven enhancer landscape defines the transcriptional architecture of retinogenesis
Development · 2025
DOI: 10.1242/dev.204986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Development, 2025. Verfasst von Fuyun Bian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA. Hauptthemen laut MEDLINE: SOXB1 Transcription Factors, Retina, Enhancer Elements, Genetic, Neurogenesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHGRI NIH HHS, NEI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Retinal neurogenesis is mediated by the coordinated activities of a complex gene regulatory network (GRN) of transcription factors (TFs) in multipotent retinal progenitor cells (RPCs). How this GRN mechanistically guides neural competence remains poorly understood. In this study, we present integrated transcriptional, genetic and genomic analyses to uncover the regulatory mechanisms of SOX2, a key factor in establishing neural identity in RPCs. We show that SOX2 is preferentially enriched in the RPC-specific enhancer landscape associated with essential regulators of retinogenesis. Disruption of SOX2 expression impairs retinogenesis, marked by a selective loss of enhancer activity near genes essential for RPC proliferation and lineage specification. We identified the RPC transcription factor VSX2 as a binding partner for SOX2 and, together, SOX2 and VSX2 co-target a core, retina-specific chromatin repertoire characterized by enhanced TF binding and robust chromatin accessibility. This cooperative binding establishes a shared SOX2-VSX2 transcriptional code that promotes the expression of crucial regulators of neurogenesis while repressing the acquisition of alternative lineage cell fate. Our data illuminate fundamental biological insights on how transcription factors act in concert to drive chromatin-based genetic programs underlying retinal neural identity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
- Department of Pharmacology and Chemical Biology and Drug Discovery Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
- Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
- Louis J Fox Center for Vision Restoration, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
ORCID-Profile: Issam Aldiri
Förderung
- NHGRI NIH HHS
- NEI NIH HHS
- NIH HHS
- Eye and Ear Foundation of Pittsburgh
- University of Pittsburgh
- Research to Prevent Blindness
- University of California
- National Institutes of Health
Zitieren
APA
Bian, F., Golestaneh, K., Davis, E., Khan, A., Nicholson, B., Daghsni, M., Flohr, K., Liu, S., da Silva, S., Pennacchio, L., & Aldiri, I. (2025). SOX2-driven enhancer landscape defines the transcriptional architecture of retinogenesis. Development. https://doi.org/10.1242/dev.204986
Vancouver
Bian F, Golestaneh K, Davis E, Khan A, Nicholson B, Daghsni M, et al. SOX2-driven enhancer landscape defines the transcriptional architecture of retinogenesis. Development. 2025. doi:10.1242/dev.204986
BibTeX
@article{Bian2025,
author = {Bian, Fuyun and Golestaneh, Kimiasadat and Davis, Emily and Khan, Abdullah and Nicholson, Brendan and Daghsni, Marwa and Flohr, Keevon and Liu, Silvia and da Silva, Susana and Pennacchio, Len and Aldiri, Issam},
title = {SOX2-driven enhancer landscape defines the transcriptional architecture of retinogenesis},
journal = {Development},
year = {2025},
doi = {10.1242/dev.204986}
}
EUVIMED